Advertisement

Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP)

      Highlights

      • Alternative payment models (APM) in gynecologic cancer may decrease cost and increase quality.
      • National data and cost modeling were used to develop an endometrial cancer APM.
      • APM cost savings may be redirected towards uncovered practice management services.

      Abstract

      Health care in the United States is in the midst of a significant transformation from a “fee for service” to a “fee for value” based model. The Medicare Access and CHIP Reauthorization Act of 2015 has only accelerated this transition. Anticipating these reforms, the Society of Gynecologic Oncology developed the Future of Physician Payment Reform Task Force (PPRTF) in 2015 to develop strategies to ensure fair value based reimbursement policies for gynecologic cancer care. The PPRTF elected as a first task to develop an Alternative Payment Model for thesurgical management of low risk endometrial cancer. The history, rationale, and conceptual framework for the development of an Endometrial Cancer Alternative Payment Model are described in this white paper, as well as directions forfuture efforts.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Miller H.D.
        Win-win-win approaches to healthcare cost control through physician-led payment reform.
        Clin. Gastroenterol. Hepatol. 2014; 12: 355-358
      1. MACRA: delivery system reform, medicare payment reform.
        (Available from:) (cited 2017)
      2. H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015.
        (Available from:) (cited 2017)
        • Porter M.E.
        A strategy for health care reform—toward a value-based system.
        N. Engl. J. Med. 2009; 361: 109-112
      3. Quality payment program.
        (Available from:) (cited 2017)
        • SGO
        Creating a new paradigm in gynecologic cancer care: policy proposals for delivery, quality and reimbursement.
        (Available from:)
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2017.
        CA Cancer J. Clin. 2017; 67: 7-30
        • Burke W.M.
        • et al.
        S. G. O. Clinical Practice Endometrial Cancer Working Group. Endometrial cancer: a review and current management strategies: part II.
        Gynecol. Oncol. 2014; 134: 393-402
        • Burke W.M.
        • et al.
        S. G. O. Clinical Practice Endometrial Cancer Working Group. Endometrial cancer: a review and current management strategies: part I.
        Gynecol. Oncol. 2014; 134: 385-392
        • Bristow R.E.
        • et al.
        Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
        Cancer. 2007; 109: 1513-1522
        • Chan J.K.
        • et al.
        Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
        Obstet. Gynecol. 2007; 109: 1342-1350
        • Salani R.
        • et al.
        Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
        Am. J. Obstet. Gynecol. 2011; 204: 466-478
        • Woo Y.L.
        • et al.
        Centralisation of services for gynaecological cancers - a Cochrane systematic review.
        Gynecol. Oncol. 2012; 126: 286-290
        • Roland P.Y.
        • et al.
        The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment.
        Gynecol. Oncol. 2004; 93: 125-130
      4. Integrated practice units.
        (Available from:) (cited 2017)
        • Porter M.E.
        Redefining Health Care: Creating Value-based Competition on Results.
        Harvard Busines School, 2006
        • French K.E.
        • et al.
        Measuring the value of process improvement initiatives in a preoperative assessment center using time-driven activity-based costing.
        Healthc. (Amst). 2013; 1: 136-142
        • Nelson G.
        • et al.
        Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations—part II.
        Gynecol. Oncol. 2016; 140: 323-332
        • Nelson G.
        • et al.
        Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations—part I.
        Gynecol. Oncol. 2016; 140: 313-322
        • Miller H.D.
        The Building Blocks of Successful Payment Reform: Designing Payment Systems That Support Higher-value Health Care.
        2009
        • Wright J.
        • et al.
        Estimating Potential for Savings for Low Risk Endometrial Cancer Using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model.
        2017
      5. Truven health analytics. MarketScan.
        (Available from:) (cited 2015 June 21)
        • Gemignani M.L.
        • et al.
        Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges.
        Gynecol. Oncol. 1999; 73: 5-11
        • Bijen C.B.
        • et al.
        Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trial.
        Gynecol. Oncol. 2011; 121: 76-82
        • Schiavone M.B.
        • et al.
        Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy.
        Am. J. Obstet. Gynecol. 2012; 207 (e1–9): 382
        • Nahas S.
        • Feigenberg T.
        • Park S.
        Feasibility and safety of same-day discharge after minimally invasive hysterectomy in gynecologic oncology: a systematic review of the literature.
        Gynecol. Oncol. 2016; 143: 439-442
        • Lee J.
        • et al.
        The safety of same-day discharge after laparoscopic hysterectomy for endometrial cancer.
        Gynecol. Oncol. 2016; 142: 508-513
        • Warren L.
        • et al.
        Open abdominal versus laparoscopic and vaginal hysterectomy: analysis of a large United States payer measuring quality and cost of care.
        J. Minim. Invasive Gynecol. 2009; 16: 581-588
        • Wright J.D.
        • et al.
        Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease.
        JAMA. 2013; 309: 689-698
        • Dessources K.
        • et al.
        Factors associated with 30-day hospital readmission after hysterectomy.
        Obstet. Gynecol. 2015; 125: 461-470
        • Classen D.C.
        • et al.
        The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.
        N. Engl. J. Med. 1992; 326: 281-286
        • Fader A.N.
        • et al.
        Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.
        Gynecol. Oncol. 2009; 114: 121-127
        • Galaal K.
        • et al.
        Laparoscopy versus laparotomy for the management of early stage endometrial cancer.
        Cochrane Database Syst. Rev. 2012; : CD006655
        • Geerts W.H.
        • et al.
        Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition).
        Chest. 2008; 133: 381S-453S
        • Malzoni M.
        • et al.
        Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study.
        Gynecol. Oncol. 2009; 112: 126-133
        • NCCN
        NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Uterine Neoplasm.
        (Available from:) (cited 2017 5.29.17; Version 2)
        • Walker J.L.
        • et al.
        Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2.
        J. Clin. Oncol. 2009; 27: 5331-5336
        • Ward K.K.
        • et al.
        Cardiovascular disease is the leading cause of death among endometrial cancer patients.
        Gynecol. Oncol. 2012; 126: 176-179
        • Zullo F.
        • et al.
        Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial.
        Am. J. Obstet. Gynecol. 2009; 200 (e1–9): 296
        • CMS
        Physician Quality Reporting System.
        (Available from:) (cited 2017)
        • Connor J.P.
        • et al.
        Computed tomography in endometrial carcinoma.
        Obstet. Gynecol. 2000; 95: 692-696
        • Novetsky A.P.
        • et al.
        The utility and management of vaginal cytology after treatment for endometrial cancer.
        Obstet. Gynecol. 2013; 121: 129-135